Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
43.39
-0.44 (-1.00%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
21,380,812
Open
43.82
Bid (Size)
43.39 (11)
Ask (Size)
43.41 (10)
Prev. Close
43.83
Today's Range
43.21 - 43.82
52wk Range
42.96 - 63.33
Shares Outstanding
2,222,113,553
Dividend Yield
5.72%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Dividend-Paying Drug Stocks to Buy at a Discount
Today 14:00 EDT
Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus
Today 6:59 EDT
From
Bristol Myers Squibb
Via
Business Wire
Performance
YTD
-23.6%
-23.6%
1 Month
-1.7%
-1.7%
3 Month
-8.7%
-8.7%
6 Month
-10.5%
-10.5%
1 Year
-17.6%
-17.6%
More News
Read More
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
Today 6:11 EDT
Via
Benzinga
Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal
October 10, 2025
Via
Stocktwits
Price Over Earnings Overview: Bristol-Myers Squibb
October 02, 2025
Via
Benzinga
Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025
October 25, 2025
From
Bristol Myers Squibb
Via
Business Wire
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
October 24, 2025
Via
MarketMinute
Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks
October 22, 2025
Via
The Motley Fool
Topics
Workforce
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
October 22, 2025
Via
MarketMinute
Why Replimune Stock Was Soaring Today
October 20, 2025
Via
The Motley Fool
2 High-Yield Dividend Stocks Too Cheap to Ignore
October 19, 2025
Via
The Motley Fool
Topics
Intellectual Property
World Trade
3 S&P 500 Stocks We Find Risky
October 17, 2025
Via
StockStory
Topics
Stocks
This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
October 16, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
October 15, 2025
Via
Benzinga
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
October 13, 2025
From
Bristol Myers Squibb
Via
Business Wire
Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines
October 12, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition
October 10, 2025
Via
Benzinga
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
October 10, 2025
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
October 10, 2025
From
Bristol Myers Squibb
Via
Business Wire
3 Value Stocks with Warning Signs
October 09, 2025
Via
StockStory
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability
October 08, 2025
Via
Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case
October 06, 2025
Via
Chartmill
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
October 02, 2025
Via
Benzinga
What's going on in today's session: S&P500 movers
October 02, 2025
Via
Chartmill
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
October 02, 2025
Via
MarketMinute
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 43.39
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 10/27/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 96.42B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 96B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.